Detalhe da pesquisa
1.
Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development.
Nat Immunol
; 21(11): 1408-1420, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868930
2.
Author Correction: Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development.
Nat Immunol
; 22(11): 1465, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34522040
3.
HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia.
Blood
; 141(14): 1737-1754, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577137
4.
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma.
Blood
; 139(16): 2471-2482, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134130
5.
Population dynamics of normal human blood inferred from somatic mutations.
Nature
; 561(7724): 473-478, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185910
6.
Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies.
Blood
; 134(24): 2195-2208, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515253
7.
BET inhibitor resistance emerges from leukaemia stem cells.
Nature
; 525(7570): 538-42, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26367796
8.
Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition.
Blood
; 131(15): 1639-1653, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463564
9.
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications.
Curr Oncol Rep
; 22(6): 61, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32476069
10.
Novel epigenetic therapies in hematological malignancies: Current status and beyond.
Semin Cancer Biol
; 51: 198-210, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782607
11.
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.
Blood
; 127(1): 29-41, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26660431
12.
CML: new tools to answer old questions.
Blood
; 135(26): 2327-2328, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32585023
13.
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
Nature
; 478(7370): 529-33, 2011 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21964340
14.
The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.
Stem Cells
; 32(9): 2324-37, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24806995
15.
FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia.
Cancer Cell
; 12(4): 367-80, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17936561
16.
Leukaemia stem cells and the evolution of cancer-stem-cell research.
Nat Rev Cancer
; 5(4): 311-21, 2005 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-15803157
17.
Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms.
Blood
; 118(6): 1610-21, 2011 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653937
18.
Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms.
Blood
; 118(1): 177-81, 2011 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21562050
19.
Hematopoietic stem cells made BETter by inhibition.
Haematologica
; 103(6): 919-921, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866885
20.
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Cancer Cell
; 7(4): 387-97, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15837627